News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Matsuda Masaru
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Matsuda Masaru (See Remark) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,875 shares
@ $0
Sold 1,830 shares
@ $7.8023, valued at
$14.3k
Granted 1,463 shares
@ $6.38, valued at
$9.3k
|
|
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/06/2023 |
4
| Matsuda Masaru (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,416 shares
@ $15.8181, valued at
$22.4k
Sold 18 shares
@ $16.52, valued at
$297.4
Granted 21,000 shares
@ $0
Granted 55,800 options to buy
@ $15.82, valued at
$882.8k
|
|
| 11/22/2022 |
4
| Matsuda Masaru (See Remark) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,875 shares
@ $0
Sold 1,720 shares
@ $18.1912, valued at
$31.3k
|
|
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Matsuda Masaru (SVP and General Counsel) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 185,000 options to buy
@ $22.79, valued at
$4.2M
|
|
| 01/05/2022 |
3
| Matsuda Masaru (SVP and General Counsel) has filed a Form 3 on Arcutis Biotherapeutics, Inc. |
| 09/07/2021 |
4
| Matsuda Masaru (SVP, General Counsel) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 3,412 shares
@ $42.22, valued at
$144.1k
Exercised 6,883 restricted stock units
@ $0 |
|
| 02/17/2021 |
4
| Matsuda Masaru (SVP, General Counsel) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 23,311 options to buy
@ $49.84, valued at
$1.2M
Granted 13,544 restricted stock units
@ $0 |
|
| 02/12/2021 |
4
| Matsuda Masaru (SVP, General Counsel) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 3,203 shares
@ $50.6, valued at
$162.1k
Paid exercise price by delivering 2,047 shares
@ $49.84, valued at
$102k
Exercised 6,257 restricted stock units
@ $0
Exercised 4,129 restricted stock units
@ $0 |
|
| 09/04/2020 |
4
| Matsuda Masaru (SVP, General Counsel) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 2,380 shares
@ $27.7, valued at
$65.9k
Exercised 6,884 restricted stock units
@ $0 |
|
| 02/13/2020 |
4
| Matsuda Masaru (SVP, General Counsel) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,681 shares
@ $20, valued at
$33.6k
Exercised 4,130 restricted stock units
@ $0 |
|
| 02/12/2020 |
4
| Matsuda Masaru (SVP, General Counsel) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 53,211 options to buy
@ $19.98, valued at
$1.1M
Granted 25,026 restricted stock units
@ $0 |
|
| 01/06/2020 |
3
| Matsuda Masaru (SVP, General Counsel) has filed a Form 3 on HALOZYME THERAPEUTICS, INC. |
|
|